• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX, INC. AFX2; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX, INC. AFX2; BIFURCATED STENT GRAFT Back to Search Results
Model Number BEA25-70/I16-30
Medical Device Problem Code Material Puncture/Hole (1504)
Health Effect - Clinical Codes Aneurysm (1708); Failure of Implant (1924)
Date of Event 10/21/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device involved in this event is excepted to be returned for evaluation but has not yet been received.Patient medical records and imaging studies will be requested for further evaluation by the clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Device iteration is afx2.
 
Event or Problem Description
The patient was initially implanted with a bifurcated stent graft and a suprarenal stent graft extension to treat an abdominal aortic aneurysm (aaa).Approximately two (2) years post initial procedure, aneurysm enlargement was identified with no endoleak confirmed.The physician elected to perform open surgery and explant the devices.During the open surgery, the physician suspects a leak from the suture holes (possible 3b endoleak) of the bifurcated stent graft.The open surgery was completed without any problems.
 
Additional Manufacturer Narrative
An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event/incident.There are no other equivalent adverse events/incidents for this lot number existing within the endologix complaint handling system.An evaluation of the returned device was completed.A visual analysis was performed and shows a small hole located approximately 2cm above the bifurcation of the device.However, endologix is unable to determine if this small hole was present prior to the device being explanted or was caused during the explanation of the device.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix was unable to confirm the reported aneurysm sac growth and type iiib endoleak of the bifurcated device event due to the lack of relevant medical information.Procedure-related harms, device, user, procedure, or anatomy relatedness of this event could not be determined with the medical records available for review.The final patient status was reported as being stable.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Device iteration is afx2.Corrections: g4 awareness date.H3 reason device not evaluated; remove data (device received and evaluated).H6 evaluation method code; remove 4144.H6 evaluation result code; remove 3233.H6 evaluation conclusion code; remove 11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX2
Common Device Name
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX, INC.
2 musick
irvine CA 92618
MDR Report Key9445728
Report Number2031527-2019-00597
Device Sequence Number3231713
Product Code MIH
UDI-Device Identifier00818009014870
UDI-Public(01)00818009014870(17)180315
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P040002
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Device Explanted Year2019
Reporter Type Manufacturer
Report Source distributor,foreign,health pr
Initial Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup
Report Date (Section B) 11/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/15/2018
Device Model NumberBEA25-70/I16-30
Device Lot Number1666976-005
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/21/2020
Initial Date Received by Manufacturer 11/10/2019
Supplement Date Received by Manufacturer01/30/2020
Initial Report FDA Received Date12/10/2019
Supplement Report FDA Received Date10/09/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
Z-0007-2019
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SUPRARENAL STENT GRAFT, LOT 1632575002.
Outcome Attributed to Adverse Event Required Intervention;
-
-